CD8A and acute myeloid leukemia: Overall, the above findings indicate that cellular and transcriptional signatures of CD8+ T cell senescence are present in newly diagnosed AML patients, and that the abundance of senescent-like T cells may correlate with antileukemia responses and OS after induction chemotherapy.